Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-26T06:06:45.807Z Has data issue: false hasContentIssue false
  • English
  • Français

Effect of dietary supplementation with βcasein A1 or A2 on markers of disease development in individuals at high risk of cardiovascular disease

Published online by Cambridge University Press:  08 March 2007

Jaye Chin-Dusting ,
Jane Shennan ,
Emma Jones ,
Carolyn Williams ,
Bronwyn Kingwell  and
Anthony Dart
Jaye Chin-Dusting*
Affiliation:
Alfred and Baker Medical Unit, Wynn Domain, Baker Heart Research Institute and Alfred Hospital, Commercial Road, Melbourne, Victoria 3004, Australia
Jane Shennan
Affiliation:
Alfred and Baker Medical Unit, Wynn Domain, Baker Heart Research Institute and Alfred Hospital, Commercial Road, Melbourne, Victoria 3004, Australia
Emma Jones
Affiliation:
Alfred and Baker Medical Unit, Wynn Domain, Baker Heart Research Institute and Alfred Hospital, Commercial Road, Melbourne, Victoria 3004, Australia
Carolyn Williams
Affiliation:
Alfred and Baker Medical Unit, Wynn Domain, Baker Heart Research Institute and Alfred Hospital, Commercial Road, Melbourne, Victoria 3004, Australia
Bronwyn Kingwell
Affiliation:
Alfred and Baker Medical Unit, Wynn Domain, Baker Heart Research Institute and Alfred Hospital, Commercial Road, Melbourne, Victoria 3004, Australia
Anthony Dart
Affiliation:
Alfred and Baker Medical Unit, Wynn Domain, Baker Heart Research Institute and Alfred Hospital, Commercial Road, Melbourne, Victoria 3004, Australia
*
*Corresponding author: Dr Jaye Chin-Dustingfax +61 3 9276 2795, email [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The present study is the first to examine the hypothesis that dietary supplementation with β-casein A1 promotes an increased risk relative to supplementation with β-casein A2 in patients traditionally at high risk of developing CVD. The study was conducted in fifteen asymptomatic participants (six male; nine female) at high risk of developing CVD. A double-blind cross-over study design was used with a total duration of 24 weeks. Dietary intervention was a daily supplementation (25g) of either casein A1 or A2 (for 12 weeks each). Surrogate measures of cardioprotection studied included the examination of vascular (endothelium and arterial) function, resting blood pressure, plasma lipids and biochemical markers of inflammation. Total plasma cholesterol levels were significantly lower following 12 weeks of both casein A1 and A2 interventions but the decrease was not different between intervention. Plasma insulin, homocysteine, C-reactive protein, fibrinogen, protein C and S and von Willebrand factor levels were not different between the two casein supplements. Endothelium function, measured as a vascular response using venous occlusion plethysmography to intra-aterial infusions of the endothelium-dependent agonist acetylcholine, were not different between the two casein interventions. Similarly, neither blood pressure nor measures of large artery stiffness were affected by differing the casein variant. We therefore conclude that there is no evidence from the present study that supplementation with casein A1 has any cardiovascular health disadvantage over consumption of casein A2.

Keywords

Milk proteinCaseinManDietary supplementationCardiovascular risk
Type
Research Article
Information
British Journal of Nutrition , Volume 95 , Issue 1 , January 2006 , pp. 136 - 144
Copyright
Copyright © The Nutrition Society 2006

References

Bassuk, SSRifai, N & Ridker, PMHigh-sensitivity C-reactive protein: clinical importance Curr Probl Cardiol (2004) 29 439–493Google Scholar
Benetos, AGautier, SRicard, S et al. Influence of angiotensinconverting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients Circulation (1996) 94 698–703CrossRefGoogle ScholarPubMed
Benetos, ATopouchian, JRicard, SGautier, SBonnardeaux, AAsmar, RPoirier, OSoubrier, FSafar, M & Cambien, FInfluence of angiotensin II type 1 receptor polymorphism on aortic stiffness in never-treated hypertensive patients Hypertension (1995) 26 44–47Google Scholar
Bisoendial, RJHovingh, GKLevels, JHLerch, PGAndresen, IHayden, MRKastelein, JJ & Stroes, ESRestoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein Circulation (2003) 107 2944–2948CrossRefGoogle ScholarPubMed
Boutouyrie, PP, AIAsmar, RGautier, IBenetos, ALacolley, P & Laurent, SAortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study Hypertension (2002) 39 10–15Google Scholar
Cameron, JD & Dart, AMExercise training increases total systemic arterial compliance in humans. Am J Physiol (1994) 266 H693–H701Google Scholar
Dairy Australia (2005) www.dairyaustralia.com.au.Google Scholar
Dart, AM & Chin-Dusting, JPLipids and the endothelium. Cardiovasc Res (1999) 43 308–322Google Scholar
Dart, AMCooper, BKay, SB & Salem, HRelationships between protein C, protein S, von Willebrand factor and euglobulin lysis time and cardiovascular risk factors in subjects with and without coronary heart disease Atherosclerosis (1998) 140 55–64Google Scholar
Dart, AM & Kingwell, BPulse pressure — a review of mechanisms and clinical relevance J Am Coll Cardiol (2001) 37 975–984Google Scholar
Davies, DT & Law, AJRThe content and composition of creamery milks in south-west Scotland. J Dairy Res (1980) 47 83–90CrossRefGoogle Scholar
El-Atat, FAStas, SNMcFarlane, SI & Sowers, JRRelationships between protein C, protein S, von Willebrand factor and euglobulin lysis time and cardiovascular risk factors in subjects with and without coronary heart disease J Am Soc Nephrol (2004) 15 2816–2827Google Scholar
Gatzka, CDCameron, JDKingwell, BA & Dart, AMRelation between coronary artery disease, aortic stiffness, and left ventricular structure in a population sample Hypertension (1998) 32 575–578Google Scholar
Gatzka, CDKingwell, BACameron, JDBerry, KLLiang, YLDewar, EMReid, CMJennings, GL & Dart, AMGender differences in the timing of arterial wave reflection beyond differences in body height J Hypertens (2001) 19 2197–2203CrossRefGoogle ScholarPubMed
Kingwell, BAWaddell, TKMedley, TLCameron, JD & Dart, AMLarge artery stiffness predicts ischemic threshold in patients with coronary artery disease. J Am Coll Cardiol (2002) 40 773–779CrossRefGoogle ScholarPubMed
Laugesen, M & Elliott, RIschaemic heart disease, type 1 diabetes, and cow milk A1 β-casein. N Z Med J (2003) 116U295Google Scholar
Laurent, SBoutouyrie, PAsmar, RGautier, ILaloux, BGuize, LDucimetiere, P & Benetos, AAortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension (2001) 37 1236–1241Google Scholar
Laurent, SKatsahian, SFassot, CTropeano, AIGautier, ILaloux, B & Boutouyrie, PAortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke (2003) 34 1203–1206Google Scholar
Lentz, SR & Haynes, WGHomocysteine: is it a clinically important cardiovascular risk factor? Cleve Clin J Med (2004) 71 729–734CrossRefGoogle ScholarPubMed
Lima, SMAdrighi, JMConsolim-Colombo, FMMansur Ade, PRubira, MCKrieger, EM & Ramines, JAAcute administration of 17b-oestradiol improves endothelin dependent vasodilatation in postmenopausal women Maturitas (2005) 50 266–274Google Scholar
McLachlan, CNSβ-Casein A1, ischaemic heart disease mortality, and other illness. Med Hypotheses (2001) 56 262–272CrossRefGoogle Scholar
McLean, DMGraham, ERBPonzoni, RW & McKenzie, HAEffects of milk protein genetic milk variants on milk yield and composition. J Dairy Sci (1984) 51 531–546Google Scholar
Medley, TLKingwell, BAGatzka, CDPillay, P & Cole, TJMMP-3 genotype contributes to age-related aortic stiffening through modulation of gene and proteinexpression Circ Res (2003) 92 1254–1261Google Scholar
Menedez, SCenterio, JAGodinez, R & Rodriguez-Otero, JLEffects of Lactobacillus strains on the ripening and organoleptic characteristics of Arzua-Ulloa cheese. Int J Food Microbiol (2000) 59 37–46CrossRefGoogle Scholar
Moncada, SNitric oxide in the vasculature: physiology and pathophysiology. Ann N Y Acad Sci (1997) 811 60–67Google Scholar
Ness, ARDavet Smith, G & Hart, CMilk, coronary heart disease and mortality. J Epidemiology Commun Health (2001) 55 379–392CrossRefGoogle ScholarPubMed
Nestel, PJPomeroy, SKay, SKomesaroff, PBehrsing, JCameron, JD & West, LIsoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women. 1999a J Clin Endocrinol Metab 84 895–898.Google Scholar
Nestel, PJPomeroy, SKay, SKomesaroff, PBehrsing, JCameron, JD & West, LIsoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women. J Clin Endocrinol Metab (1999b) 84 3647Google Scholar
Nestel, PJYamashita, TSasahara, TPomeroy, SDart, AKomesarof, POwen, A & Abbey, MSoy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. Arterioscler Thromb Vasc Biol (1997) 17 3392–3398CrossRefGoogle Scholar
Shaw, JAChin-Dusting, JPKingwell, BADart, AMDiurnal variation in endothelium-dependent vasodilatation is not apparent in coronary artery disease. Circulation (2001) 103 806–812CrossRefGoogle Scholar
Spieker, LESudano, IHurlimann, DLerch, PGLang, MGBinggeli, CCorti, RRuschitzka, FLüscher, TF & Noll, GHigh-density lipoprotein restores endothelial function in hypercholesterolemic men. Circulation (2002) 105 1399–1402Google Scholar
Steinerova, AKorotvicka, MRacek, JRajdl, DTrefil, LStozicky, FRokyta, ZSignificant increase in antibodies against oxidized LDL particles (IgoxLDL) in three-month old infants who received milk formula (letter to editor). Atherosclerosis (2004) 173 147–148Google Scholar
Sugawara, JInoue, HHayashi, KYokoi, T & Kono, IEffect of low intensity aerobic exercise training on arterial compliance in post-menopausal women. Hypertens Res (2004) 27 897–901Google Scholar
Tailford, KABerry, CLThomas, AC & Campbell, JHA casein variant in cow's milk is atherogenic. Atherosclerosis (2003) 170 13–19CrossRefGoogle ScholarPubMed
Waddell, TDart, AMedley, TCameron, JD &Kingwell, BACarotid pressure is a better predictor of coronary artery disease severity than brachial pressure Hypertension (2001) 38 927–931CrossRefGoogle ScholarPubMed
Yusuf, SHawken, SÔunpuu, SDans, TAvezum, ALanas, FMcQueen, MBudaj, APais, P & Varigos, JEffect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet (2004) 364 937–952Google Scholar